Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403426 · ClinicalTrials.gov registry record · NA
ReFlow Medical Wingman Catheter Wing-IT Clinical Trial
A NA study, sponsored by ReFlow Medical.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT03403426 is a NA study that has completed, run by ReFlow Medical. The registered enrollment target is 85 participants.
The verdict
NCT03403426, a NA study, has completed, sponsored by ReFlow Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the ReFlow Medical Wingman Catheter used to cross de novo or restenotic infrainguinal CTOs that cannot be crossed with a standard guidewire.
Interventions
- DEVICE Wingman Crossing Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2019-08-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03403426
The ClinicalTrials.gov registry entry for NCT03403426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ReFlow Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wingman Crossing Catheter is the first listed.
NCT03403426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03403426 about?
NCT03403426 is a clinical study titled "ReFlow Medical Wingman Catheter Wing-IT Clinical Trial". To evaluate the safety and effectiveness of the ReFlow Medical Wingman Catheter used to cross de novo or restenotic infrainguinal CTOs that cannot be crossed with a standard guidewire.
What is the current status of trial NCT03403426?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2018-02-13. Estimated completion is 2019-08-08.
What interventions are being tested in trial NCT03403426?
The interventions under investigation include: Wingman Crossing Catheter (DEVICE).
Who is sponsoring clinical trial NCT03403426?
This trial is sponsored by ReFlow Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.